CGEM Insider Transactions — Page 3
386 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| BVF II GP LLC | Other | 2022-05-12 | Purchase | 457,001.0 | $9.06 |
| BVF GP HOLDINGS LLC | TenPercentOwner | 2022-05-12 | Purchase | 457,001.0 | $9.06 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF INC/IL | TenPercentOwner | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| LAMPERT MARK N | TenPercentOwner | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF Partners OS Ltd. | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF I GP LLC | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF II GP LLC | Other | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BVF GP HOLDINGS LLC | TenPercentOwner | 2022-05-12 | Purchase | 542,999.0 | $9.06 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF INC/IL | TenPercentOwner | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| LAMPERT MARK N | TenPercentOwner | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF Partners OS Ltd. | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF I GP LLC | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF II GP LLC | Other | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BVF GP HOLDINGS LLC | TenPercentOwner | 2022-04-01 | Purchase | 9,402.0 | $10.75 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF INC/IL | TenPercentOwner | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| LAMPERT MARK N | TenPercentOwner | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF Partners OS Ltd. | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF I GP LLC | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF II GP LLC | Other | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| BVF GP HOLDINGS LLC | TenPercentOwner | 2022-04-01 | Purchase | 266,598.0 | $10.75 |
| Michaelson Jennifer | See Remarks | 2021-10-18 | Sale | 400.0 | $23.61 |
| Michaelson Jennifer | See Remarks | 2021-10-18 | Sale | 204.0 | $22.4 |
| Michaelson Jennifer | See Remarks | 2021-10-18 | Sale | 3,396.0 | $21.1 |
| Trigilio Jeffrey | Chief Financial Officer | 2021-10-15 | Sale | 8,000.0 | $25.0 |
| Zawel Leigh | See Remarks | 2021-10-15 | Sale | 19,574.0 | $25.0 |
| Zawel Leigh | See Remarks | 2021-10-07 | Sale | 1,079.0 | $25.0 |
| Michaelson Jennifer | See Remarks | 2021-09-20 | Sale | 800.0 | $25.2 |
| Michaelson Jennifer | See Remarks | 2021-09-20 | Sale | 3,200.0 | $24.34 |
| Zawel Leigh | See Remarks | 2021-09-20 | Sale | 7,468.0 | $25.16 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-16 | Sale | 3,124.0 | $29.06 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-16 | Sale | 3,124.0 | $29.06 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-16 | Sale | 3,124.0 | $29.06 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-16 | Sale | 3,124.0 | $29.06 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-16 | Sale | 432.0 | $29.06 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-15 | Sale | 6,425.0 | $29.16 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-15 | Sale | 6,425.0 | $29.16 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-15 | Sale | 6,425.0 | $29.16 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-15 | Sale | 6,425.0 | $29.16 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-15 | Sale | 888.0 | $29.16 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-14 | Sale | 7,106.0 | $29.17 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-14 | Sale | 7,106.0 | $29.17 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-14 | Sale | 7,106.0 | $29.17 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-14 | Sale | 7,106.0 | $29.17 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-14 | Sale | 982.0 | $29.17 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-13 | Sale | 3,595.0 | $29.1 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-13 | Sale | 3,595.0 | $29.1 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-13 | Sale | 3,595.0 | $29.1 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-13 | Sale | 3,595.0 | $29.1 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-13 | Sale | 497.0 | $29.1 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-10 | Sale | 5,931.0 | $29.04 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-10 | Sale | 5,931.0 | $29.04 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-10 | Sale | 5,931.0 | $29.04 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-10 | Sale | 5,931.0 | $29.04 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-10 | Sale | 820.0 | $29.04 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-09 | Sale | 13,727.0 | $29.35 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-09 | Sale | 13,727.0 | $29.35 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-09 | Sale | 13,727.0 | $29.35 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-09 | Sale | 13,727.0 | $29.35 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-09 | Sale | 1,898.0 | $29.35 |
| Trigilio Jeffrey | Chief Financial Officer | 2021-09-08 | Sale | 9,513.0 | $28.85 |
| Trigilio Jeffrey | Chief Financial Officer | 2021-09-08 | Sale | 5,487.0 | $27.83 |
| Baeuerle Patrick | See Remarks | 2021-09-08 | Sale | 11,000.0 | $28.45 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-08 | Sale | 10,842.0 | $29.11 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-08 | Sale | 10,842.0 | $29.11 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-08 | Sale | 10,842.0 | $29.11 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-08 | Sale | 10,842.0 | $29.11 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-08 | Sale | 1,499.0 | $29.11 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-07 | Sale | 25,067.0 | $29.04 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-07 | Sale | 25,067.0 | $29.04 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-07 | Sale | 25,067.0 | $29.04 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-07 | Sale | 25,067.0 | $29.04 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-07 | Sale | 3,465.0 | $29.04 |
| Zawel Leigh | See Remarks | 2021-09-07 | Sale | 28,118.0 | $28.95 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-03 | Sale | 12,731.0 | $29.6 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-03 | Sale | 12,731.0 | $29.6 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-03 | Sale | 12,731.0 | $29.6 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-03 | Sale | 12,731.0 | $29.6 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-03 | Sale | 1,760.0 | $29.6 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-02 | Sale | 15,757.0 | $29.46 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-02 | Sale | 15,757.0 | $29.46 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-02 | Sale | 15,757.0 | $29.46 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-02 | Sale | 15,757.0 | $29.46 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-02 | Sale | 2,178.0 | $29.46 |
| BioImpact Capital LLC | TenPercentOwner | 2021-09-01 | Sale | 5,714.0 | $29.47 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2021-09-01 | Sale | 5,714.0 | $29.47 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2021-09-01 | Sale | 5,714.0 | $29.47 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-01 | Sale | 5,714.0 | $29.47 |
| GADICKE ANSBERT | Director,TenPercentOwner | 2021-09-01 | Sale | 790.0 | $29.47 |